# HYDROCHLORIC ACID URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid2020711 Categories: cleaning, food, industrial, pharma Functions: Anti-scaling agent, Biocide, Chelating agent, Cleaning agent, Other, Processing aids not otherwise specified, coatings & finishing treatments, pH regulating agent Identifier: DTXSID2020711 > HYDROCHLORIC ACID is used as anti-scaling agent / biocide. EPA CPDat observed this chemical in 2204 composition records across product categories including Cleaning products and household care, Industrial products, Laboratory supplies. Assessed from 157 sources. ## Safety assessment - Chemical concern: not yet assessed - Rationale: EPA CPDat observed this chemical in 2204 composition records across product categories including Cleaning products and household care, Industrial products, Laboratory supplies. ## Regulatory status - US: commercial use observed — EPA CPDat observed this chemical in 2204 composition records across product categories including Cleaning products and household care, Industrial products, Laboratory supplies. EPA CPDat classifies this chemical for functional uses including pH regulating agent, Cleaning agent, Anti-scaling agent. - US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.37 %w/v - US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.04 %w/v - US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: DENTAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: DENTAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: ENDOTRACHEAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: ENDOTRACHEAL; Dosage form: POWDER, FOR SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: EPIDURAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: EPIDURAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: EPIDURAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: EXTRACORPOREAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: EXTRACORPOREAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INFILTRATION; Dosage form: INJECTION; Potency: 0.37 %w/v - US: inactive ingredient database — Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTERSTITIAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-AMNIOTIC; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION; Maximum daily exposure: 840 mg - US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRABURSAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACARDIAC; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACARDIAC; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACAUDAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACAUDAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACAVERNOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACAVITARY; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACAVITARY; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRADERMAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRADERMAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 306 mg - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, EMULSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1037 mg - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: LIQUID; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: 5 mg - US: inactive ingredient database — Route: INTRAOCULAR; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAOCULAR; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAPERITONEAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAPERITONEAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAPLEURAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRASPINAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATHECAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATHECAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATHECAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATHECAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATHECAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATUMOR; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATUMOR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATYMPANIC; Dosage form: SUSPENSION; Maximum daily exposure: 1 mg - US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTABLE, LIPOSOMAL; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 720 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 0.18 %w/v - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Potency: 4.17 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 160 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1037 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION, LIPOSOMAL; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: LIQUID; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: POWDER; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 18.25 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION, CONCENTRATE; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVESICAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 157 mg - US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: IONTOPHORESIS; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: IRRIGATION; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: NASAL; Dosage form: DROPS; Potency: 10 ml - US: inactive ingredient database — Route: NASAL; Dosage form: LIQUID; Potency: ADJ PH - US: inactive ingredient database — Route: NASAL; Dosage form: SOLUTION; Potency: 91.7 mg/100ml - US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Potency: 10 ml - US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY, METERED; Potency: ADJ PH - US: inactive ingredient database — Route: NASAL; Dosage form: SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: EMULSION; Potency: ADJ PH - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: GEL; Potency: ADJ PH - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.31 %w/v - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 7 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Potency: ADJ PH - US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Potency: 2.17 mg/1ml - US: inactive ingredient database — Route: ORAL; Dosage form: LIQUID; Potency: 4.46 mg/1ml - US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 125 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 223 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Potency: 100 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: ADJ PH - US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Potency: 2.03 mg/1ml - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 2.32 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 24 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: ADJ PH - US: inactive ingredient database — Route: PARENTERAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: PARENTERAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: PARENTERAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: PERIDURAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: PERINEURAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: RECTAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: AEROSOL, METERED; Potency: 0.7 %w/w - US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: AEROSOL, SPRAY; Potency: 1.5 %w/w - US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: SPRAY; Potency: ADJ PH - US: inactive ingredient database — Route: RETROBULBAR; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBARACHNOID; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCONJUNCTIVAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, EMULSION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1037 mg - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: 5 mg - US: inactive ingredient database — Route: SUBMUCOSAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBMUCOSAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Potency: 2.1 %w/w - US: inactive ingredient database — Route: TOPICAL; Dosage form: EMULSION; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: GEL; Potency: 0.5 %w/w - US: inactive ingredient database — Route: TOPICAL; Dosage form: JELLY; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Potency: NA - US: inactive ingredient database — Route: TOPICAL; Dosage form: SHAMPOO; Maximum daily exposure: 104 mg - US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: SPONGE; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: URETERAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: URETHRAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: URETHRAL; Dosage form: SOLUTION; Potency: ADJ PH - US: marketed drug occurrence — FDA NDC lists this ingredient in 35 active drug products and 37 total products. - US: listed in openFDA substance — openFDA substance registry classifies this ingredient as concept. - US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical. _Assessed by Greenveil._